News 2021-04-21
2021 Pharmaceutical Crystallization Summit
Breaking Drug Development Bottlenecks via Enabling Technologies
Physical & chemical properties of drug substance (DS) have major impacts on the formulation process & Drug Product (DP) properties or quality attributes. The final step in an API synthesis is usually crystallization or precipitation, serving as both purification and isolation. This international conference gathers industrial and academic subject matter experts to discuss their works related to DS crystallization and manufacturing opportunities (highlighted below)for new drug development programs.
(1) crystal structure prediction, (2) crystal shape prediction, (3) solubility assessment, (4) purification, and (5) analytical technologies
(1) co-processed API’s, (2) process intensification, (3) additive manufacturing, (4) adv. process control & automation, (5)modular systems
Please Click the image below to see more details.
Others
More
News 2025-10-20
Porton Warmly Congratulates Partner XZenith on Its Listing on the Main Board of the Hong Kong Stock Exchange
Porton congratulates XZenith on its HK listing, highlighting our CDMO partnership for innovative drug development and commercialization.

News 2025-10-10
Porton Newsletter - September 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities Others
